The NIMO Scandinavian Study: A Prospective Observational Study of Iron Isomaltoside Treatment in Patients with Iron Deficiency

Figure 3

Change in haemoglobin (Hb) after the first iron isomaltoside treatment in anaemic patients with available pre- and posttreatment Hb measures. The time of evaluation corresponded to the time between the last administration of first iron isomaltoside treatment and blood test follow-up and occurred during a mean (SD) time of 7.1 (6.0) weeks for anaemic patients at baseline and during a mean (SD) time of 6.1 (4.7) weeks for patients with Hb < 10 g/dL at baseline. The value calculations were obtained by analysis of covariance test with diagnosis and dose as factors and pretreatment laboratory parameter concentration as covariate.